Stump_2009_Bioorg.Med.Chem.Lett_19_214

Reference

Title : The discovery of highly potent CGRP receptor antagonists - Stump_2009_Bioorg.Med.Chem.Lett_19_214
Author(s) : Stump CA , Bell IM , Bednar RA , Bruno JG , Fay JF , Gallicchio SN , Johnston VK , Moore EL , Mosser SD , Quigley AG , Salvatore CA , Theberge CR , Blair Zartman C , Zhang XF , Kane SA , Graham SL , Vacca JP , Williams TM
Ref : Bioorganic & Medicinal Chemistry Lett , 19 :214 , 2009
Abstract :

Rational modification of a previously identified spirohydantoin lead structure has identified a series of potent spiroazaoxindole CGRP receptor antagonists. The azaoxindole was found to be a general replacement for the hydantoin that consistently improved in vitro potency. The combination of the indanylspiroazaoxindole and optimized benzimidazolinones led to highly potent antagonists (e.g., 25, CGRP K(i)=40pM). The closely related compound 27 demonstrated good oral bioavailability in dog and rhesus.

PubMedSearch : Stump_2009_Bioorg.Med.Chem.Lett_19_214
PubMedID: 19010673

Related information

Citations formats

Stump CA, Bell IM, Bednar RA, Bruno JG, Fay JF, Gallicchio SN, Johnston VK, Moore EL, Mosser SD, Quigley AG, Salvatore CA, Theberge CR, Blair Zartman C, Zhang XF, Kane SA, Graham SL, Vacca JP, Williams TM (2009)
The discovery of highly potent CGRP receptor antagonists
Bioorganic & Medicinal Chemistry Lett 19 :214

Stump CA, Bell IM, Bednar RA, Bruno JG, Fay JF, Gallicchio SN, Johnston VK, Moore EL, Mosser SD, Quigley AG, Salvatore CA, Theberge CR, Blair Zartman C, Zhang XF, Kane SA, Graham SL, Vacca JP, Williams TM (2009)
Bioorganic & Medicinal Chemistry Lett 19 :214